Diagnostic of Various Ototoxicity Induced by Cancer Treatment
Recruiting
Observational Study
Ototoxicity, Drug-Induced
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 540 (estimated)
- Sponsor
- Direction Centrale du Service de Santé des Armées · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
• Visit the clinic once every 2 weeks for checkups and tests The goal of this clinical trial is to learn if systematic hearing tests (eg fonctional assesment, electrophysiology and seric biomarkers) can diagnose hidden hearing loss or vestibular troubles in a population of patients treated for cancer; population study will include different population in terms of sex/gender, age, medical condition…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age 18 and over
* Registered with social security
* Signed consents
* Absence of presbycusis prior to cancer treatment (groups A and C)
* No known presbycusis (group B)
* Previous exposure to an ototoxic/neurotoxic agent (group A)
* Indication for initiation of ototoxic/neurot…
Contacts